Liangkun You

Sir Run Run Shaw Hospital — China

Medicine · Health Sciences

13h-index1.2kcitations31works2.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(7), MicroRNA in disease regulation(6), Autophagy in Disease and Therapy(6), Cancer-related molecular mechanisms research(5), Lung Cancer Research Studies(4)

Publications31 total

Distinct clinical features and epidemiological trends of very early and middle-aged early onset colorectal cancer based on SEER 17 and GBD 2021 data over the past 15 years
BMC Cancer·2025Open Access
Response to anaplastic lymphoma kinase inhibitor in gastric cancer harboring DCTN1–ALK fusion: a case report and review
Frontiers in Immunology·2025Open Access
Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report
Frontiers of Medicine·2025· 2 cited
Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents
Frontiers in Pharmacology·2024· 2 citedOpen Access
Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasis
Scientific Reports·2024· 5 citedOpen Access
Enhancing First-Line TKI Efficacy in PD-L1-Positive EGFR-Mutated NSCLC: The Role of Antiangiogenic Agents
Research Square (Research Square)·2024Open Access
Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review
BMC Geriatrics·2024· 10 citedOpen Access
Autophagy in colitis-associated colon cancer: exploring its potential role in reducing initiation and preventing IBD-Related CAC development
Autophagy·2023· 37 citedOpen Access
Development and Validation of a Disulfidptosis-Related lncRNA Prognostic Risk Model for Cervical Cancer
Research Square (Research Square)·2023Open Access
The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study
Scientific Reports·2022· 6 citedOpen Access
Integrated bioinformatics analysis reveals correlations of high TRIM59 expression with worse prognosis and immune infiltrates in lung adenocarcinoma
Journal of Bio-X Research·2021· 2 citedOpen Access
The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer
Frontiers in Oncology·2021· 26 citedOpen Access
Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study
International Immunopharmacology·2020· 21 cited
Author Correction: Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
Scientific Reports·2020· 3 citedOpen Access
Corrigendum to “Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3” [Canc Lett 379 (2016) 124–133]
Cancer Letters·2020· 1 cited
High TRIM59 Expression Predicts Adverse Outcomes and Is Correlated with Immune Infiltrates in Lung Adenocarcinoma
SSRN Electronic Journal·2020Open Access
CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma
Aging·2019· 93 citedOpen Access
Exploring the role of Mir204/211 in HNSCC by the combination of bioinformatic analysis of ceRNA and transcription factor regulation
Oral Oncology·2019· 6 citedOpen Access
Lymph node involvement in pancreatic neuroendocrine tumors: significance as a predictor of survival
Journal of Bio-X Research·2019· 3 citedOpen Access
Comprehensive Analysis of a circRNA-Mediated Competing Endogenous RNA Network in Pancreatic Adenocarcinoma
SSRN Electronic Journal·2019Open Access
page 1 of 2Next →

Frequent Co-authors

Hongming Pan(20), Weidong Han(19), Jiawei Shou(12), Ju-Jun Xie(8), Chongya Zhai(7), Xuanhong Jin(7), Xinbing Sui(5), Junlin Yao(5), Liming Jiang(5), Zhanggui Wang(4), Jing Zhao(4), Yongde Liao(4), Binbin Xie(4), Pan Yang(4), Hongsen Li(3), Jing Zhao(3), Rongjie Zhao(3), Weiting Ge(3), Wendong Huang(3), Hexiao Tang(3)